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Abstract Phosphorylation of elongation factor-2 (eEF-2) by the
highly specific eEF-2 kinase results in eEF-2 inactivation and,
therefore, may regulate the global rate of protein synthesis in
animal cells. Cloning and sequencing of eEF-2 kinase led to the
discovery of a new family of protein kinases, named K-kinases,
whose catalytic domains display no sequence homology to
conventional eukaryotic protein kinases. Several mammalian
K-kinases have recently been cloned. Two of these K-kinases,
named channel-kinases 1 and 2 (ChaK1 and ChaK2) represent a
new type of signaling molecules that are protein kinases fused to
ion channels. ß 2002 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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Phosphorylation of elongation factor-2 (eEF-2) was discov-
ered in the laboratory of A.S. Spirin [1^4]. It was found that
eEF-2 is one of the most prominently phosphorylated proteins
in mammalian tissue extracts [1]. It was also found that phos-
phorylation of eEF-2 results in its inactivation, and, therefore,
may represent the mechanism of global protein synthesis reg-
ulation at the elongation stage [2]. Phosphorylation of eEF-2
is catalyzed by a very speci¢c eEF-2 kinase [3], which was
identi¢ed earlier and previously called calcium/calmodulin-de-
pendent protein kinase III [5,6]. Since eEF-2 kinase is calci-
um-dependent and since phosphorylation inactivates eEF-2, it
was initially suggested that eEF-2 phosphorylation represents
the mechanism by which changes in intracellular calcium con-
centration regulate the rate of protein synthesis. However,
recent experiments question the role of eEF-2 phosphoryla-
tion in the regulation of protein synthesis by calcium in vivo
[7]. It is now clear that the regulation of eEF-2 kinase is quite
complex. It was found that several di¡erent protein kinases
can phosphorylate eEF-2 kinase and that these phosphoryla-
tions can a¡ect eEF-2 kinase activity. These protein kinases
include cAMP-dependent protein kinase [8^11], stress-acti-
vated protein kinase SAPK4/p38N [12], p90RSK1 and p70 S6
kinase [13].
Recently we found another mechanism of regulation of
eEF-2 kinase, which may provide a clue to the physiological
role of eEF-2 phosphorylation. We found that eEF-2 kinase is
dramatically activated by a slight decrease in pH, in the range
that is observed intracellularly during hypoxia and ischemia.
At normal physiological pH (7.4) eEF-2 kinase activity is very
low, but increases drastically at pH 6.4^6.8 (Fig. 1). This
result suggests that phosphorylation of eEF-2 may play a
role in the inhibition of protein synthesis during hypoxia
and ischemia. Since inhibition of protein synthesis can often
protect cells from death, it is possible that the pH-dependent
phosphorylation of eEF-2 is part of a protective signaling
mechanism that is activated during hypoxia and ischemia.
To uncover the physiological role of eEF-2 kinase we made
knockouts of eEF-2 kinase in Caenorhabditis elegans and
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Fig. 1. pH dependence of protein phosphorylation in liver homoge-
nates from wild-type and eEF-2 kinase knockout mice. Liver homo-
genates were clari¢ed by centrifugation for 10 min at 10 000Ug at
4‡C and added in reaction mixtures consisting of 50 mM HEPES-
KOH with variable pH, 10 mM magnesium acetate, 5 mM dithio-
threitol, 100 WM CaCl2, 60 WM ATP, and 1 WCi [Q-33P]ATP. The re-
actions were run at 30‡C for 10 min, and were terminated by incu-
bation in an ice^water bath. Laemmli sample bu¡er was added, and
the reaction mixtures were boiled for 5 min. Samples were analyzed
by 8% SDS^PAGE and autoradiography.
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mice. Loss of eEF-2 kinase completely eliminated eEF-2 phos-
phorylation in the tissues of knockout animals (see Fig. 1).
Surprisingly, both nematodes and mice lacking eEF-2 kinase
were essentially normal; no obvious abnormalities in develop-
ment, reproduction, or behavior were observed. Thus, eEF-2
kinase is not essential for viability, however it may play a role
in the response to stress.
When we cloned and sequenced mammalian and C. elegans
eEF-2 kinases, we found that they did not display sequence
homology to any conventional eukaryotic protein kinase [14].
However, they displayed striking similarity to the catalytic
domain of the myosin heavy chain kinase A (MHCK A)
from Dictyostelium [15,16]. Two more protein kinases with a
similar catalytic domain structure have been identi¢ed in Dic-
tyostelium and were named MHCK B [17] and MHCK C [18].
Since eEF-2 kinase and Dictyostelium MHCKs do not display
homology to conventional eukaryotic protein kinases, they
clearly represent a separate family of protein kinases. We
named this family K-kinases, because the existing evidence
suggests that these kinases phosphorylate their substrates
within K-helices [19]. Particularly striking is MHCK A, which
phosphorylates three threonine residues located in the K-hel-
ical coiled-coil tail of myosin heavy chains [20,21]. This is very
di¡erent from conventional protein kinases that phosphory-
late their substrates within loops, turns, or regions with irreg-
ular structure [22]. K-Kinases have a catalytic domain of
about 250 amino acids, which is characterized by several con-
served motifs [19].
Recently, we identi¢ed, cloned, and sequenced ¢ve more
human K-kinases [19,23]. All these new K-kinases are very
long proteins of more than 1000 amino acids, with an K-ki-
nase catalytic domain located at the very C-terminus. Unex-
pectedly, we found that two of them represent a novel type of
signaling molecule, in which an K-kinase catalytic domain is
fused to an ion channel. Initially we named these proteins
melanoma K-kinase and kidney K-kinase [19,23] and then re-
named them channel-kinases 1 and 2 (ChaK1 and ChaK2,
GenBank accession numbers AAK19738 and AAK31202, re-
spectively). During the past year several other laboratories
independently cloned and characterized mouse and human
ChaK1 and named it TRP-PLIK [24], LTRPC7 [25], or
ChaK [26]. ChaK1, as well as ChaK2, represent the ¢rst ex-
amples of ion channels that are also enzymes and have protein
kinase activity. The channel portions of ChaK1 and ChaK2
are homologous to the transient receptor potential (TRP)
family of ion channels. TRP channels are homologs of the
Drosophila TRP channel, a calcium channel that is involved
in photoreception. The majority of TRP channels are Ca2
permeable non-selective cation channels that can be subdi-
vided into several subgroups (reviewed in [27^29]). ChaK1
and ChaK2 belong to one such subgroup, named long TRP
channels (LTRPC) [27] or the TRPM subfamily [29]. The
LTRPC (TRPM) subfamily is characterized by a very long
N-terminus with a unique and highly conserved sequence.
ChaK1 and ChaK2 are particularly similar to melastatin, a
channel that is speci¢cally down-regulated in metastatic mel-
anoma [30,31]. It is likely that ChaK1 and ChaK2 are prod-
ucts of a recent evolutionary event ^ a fusion of a gene for an
K-kinase catalytic domain and a gene for a melastatin-like ion
channel. According to Northern analysis, ChaK1 is expressed
Fig. 2. Schematic representation of known proteins with an K-kinase domain. The accession numbers are as follows: human eEF-2 kinase
(XM_012488), C. elegans eEF-2 kinase (AAB58268), Dictyostelium MHCK A (P42527), Dictyostelium MHCK B (P90648), Dictyostelium
MHCK C (AAC31918), human ChaK1 (AAK19738), human ChaK2 (AAK31202), human lymphocyte K-kinase (AAK94675), human heart
K-kinase (NP_443179), human muscle K-kinase (AAK95951), Neurospora K-kinase (CAC18305), Trypanosoma K-kinase (AC079815).
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in all mammalian tissues and cell lines tested, while ChaK2 is
expressed only in some tissues, being most abundant in kid-
neys [23]. The exact function of channel kinases is unknown,
although experiments with targeted deletion of ChaK1
(LTRPC7) in DT-40 B cells demonstrated that this gene is
essential for viability [25]. It is also unclear whether the
main purpose of having a protein kinase covalently linked
to an ion channel is to regulate the channel by the kinase or
to regulate the kinase by the channel. Runnels et al. [24]
provided evidence that kinase activity is required for ChaK1
(TRP-PLIK) ion channel activity; however, this conclusion
was challenged by another group [25]. This group also showed
that the ion channel activity of ChaK1 (LTRPC7) is modu-
lated by Mg2 and ATP [25].
Another protein with the K-kinase catalytic domain, which
we cloned from a lymphocyte cDNA library and called lym-
phocyte K-kinase, has four predicted transmembrane segments
close to its N-terminus [23]. However, this region is not ho-
mologous to any ion channel. Interestingly, the pattern of
expression of lymphocyte K-kinase is very similar to ChaK1
[23], suggesting that these two proteins have a common mode
of regulation and perhaps related functions.
The two other mammalian proteins with the K-kinase cata-
lytic domain, named heart K-kinase and muscle K-kinase, are
expressed predominantly in heart and skeletal muscle [23].
Both the heart and muscle K-kinases have an Ig-like domain
preceding the catalytic domain. Recently, a mouse homolog of
muscle K-kinase has been cloned and named Midori [32].
Midori is a nuclear protein that is expressed in the heart early
during development and can regulate cardiomyocyte di¡eren-
tiation [32].
Thus in humans, and perhaps in other mammals, there are
six K-kinases. Analysis of the completed human genome se-
quence revealed the location of all six K-kinases on various
chromosomes and did not reveal any other genes whose prod-
ucts contain an K-kinase domain. Analysis of various genome
sequencing data revealed that C. elegans has only one K-ki-
nase, eEF-2 kinase. There are no K-kinases in Drosophila,
Arabidopsis, or yeast genomes; however, there is one protein
encoded in the Neurospora genome with a typical K-kinase
domain (GenBank accession number CAC18305). This pro-
tein also contains a von Willebrand factor type A domain, a
module that is present in many proteins (mostly extracellular
matrix proteins) and that can interact with various ligands.
There are probably many K-kinases in protozoan genomes,
since the genomes of Trypanosoma, Leishmania and Entamoe-
ba each contain several DNA sequences that encode hypo-
thetical proteins with K-kinase domains. A schematic repre-
sentation of all currently known proteins having K-kinase
domains is shown in Fig. 2. The phylogenetic relationship
of these proteins is shown in Fig. 3.
Recently K-kinases gave another surprise. When the three-
dimensional structure of mouse ChaK1 was determined [26],
it appeared that the fold of the K-kinase catalytic domain is
similar to conventional eukaryotic protein kinases, despite
the absence of similarity at the amino acid sequence level.
The major structural di¡erence was in the putative sub-
strate-binding region [26]. This suggests that K-kinases are
evolutionarily related to conventional eukaryotic protein
kinases and utilize a similar catalytic mechanism, but
that they may have a di¡erent mechanism of substrate recog-
nition.
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